NEAT1 knockdown further decreased cell growth in cisplatin- or taxol-treated cells, demonstrating a synergistic effect of the combination of shNEAT1 and chemotherapeutic drugs in breast cancer (Fig. 3b). This evidence concerns the gene NEAT1 and breast cancer.